Cardiff Lexington Corp. Files 2023 Annual Report Amendment

TL;DR

Cardiff Lexington Corp. filed an amendment to its 2023 10-K, updating financials. Check for changes.

AI Summary

Cardiff Lexington Corp. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2023. The filing, dated July 24, 2024, provides updated financial information. The company, previously known as Cardiff International Inc., is incorporated in Florida and operates in the medical offices and clinics sector.

Why It Matters

This amendment provides updated financial disclosures for Cardiff Lexington Corp., which is crucial for investors to assess the company's financial health and performance for the 2023 fiscal year.

Risk Assessment

Risk Level: low — This filing is an amendment to a previous annual report and does not appear to introduce new material risks or significant negative events.

Key Numbers

• 20231231 — Fiscal Year End (The period covered by the amended financial statements.)
• 20240724 — Filing Date (The date the amendment was submitted to the SEC.)

Key Players & Entities

• Cardiff Lexington Corp. (company) — Filer of the 10-K/A
• 20231231 (date) — Fiscal year end for the report
• 20240724 (date) — Filing date of the amendment
• Cardiff International Inc. (company) — Former company name

FAQ

Key Financial Figures

• $0.001 — Section 12(g) of the Act: Common Stock, $0.001 par value Indicate by check mark if th

Filing Documents

• cardiff_i10ka1-123123.htm (10-K/A) — 1862KB
• image_002.jpg (GRAPHIC) — 75KB
• cardiff_10k-ex3101.htm (EX-31.1) — 11KB
• cardiff_10k-ex3102.htm (EX-31.2) — 11KB
• cardiff_10k-ex3201.htm (EX-32.1) — 4KB
• cardiff_10k-ex3202.htm (EX-32.2) — 4KB
• 0001683168-24-005025.txt ( ) — 8554KB
• cdif-20231231.xsd (EX-101.SCH) — 63KB
• cdif-20231231_cal.xml (EX-101.CAL) — 69KB
• cdif-20231231_def.xml (EX-101.DEF) — 228KB
• cdif-20231231_lab.xml (EX-101.LAB) — 427KB
• cdif-20231231_pre.xml (EX-101.PRE) — 355KB
• cardiff_i10ka1-123123_htm.xml (XML) — 1456KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations. 37 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk. 48 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data. 48 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 48 Item 9A.

Controls and Procedures

Controls and Procedures. 48 Item 9B. Other Information. 50 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 50 PART III Item 10. Directors, Executive Officers and Corporate Governance. 51 Item 11.

Executive Compensation

Executive Compensation. 54 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 59 Item 13. Certain Relationships and Related Transactions, and Director Independence. 60 Item 14. Principal Accounting Fees and Services. 60 PART IV Item 15. Exhibit and Financial Statement Schedules. 61 Item 16. Form 10-K Summary. 63 i INTRODUCTORY NOTES Use of Terms Except as otherwise indicated by the context and for the purposes of this report only, references in this report to "we," "us," "our" and "our company" are to Cardiff Lexington Corporation, a Nevada corporation, and its consolidated subsidiaries. Special Note Regarding Forward-Looking Statements This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on our management's beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts are forward-looking statements. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about: our ability to successfully identify and acquire additional businesses; our ability to effectively integrate and operate the businesses that we acquire; our expectations around the performance of our current businesses; our ability to maintain our business model and improve our capital efficiency; our ability to effectively manage the growth of our business; our ability to maintain profitabil

View Full Filing

View this 10-K/A filing on SEC EDGAR